Therapeutics Acquisition Corp. (RACA) is a Business Services company listed on NASDAQ. There were no new wire items for RACA in the last 30 days. The most recent was published Jul 8, 2021.
Latest news
25 items- INSIDERSEC Form 4 filed by Lubner David Charles4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by Malik Rajesh4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by MARGOLIN YAEL4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by GOTTLIEB MICHAEL M.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by HOGUE GERALD L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by FLESHNER NEIL E.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by DEMERS WILLIAM L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by GILMOUR MARGARET E.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by JENSEN JESSICA D.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by GOODMAN JONATHAN R.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SECTherapeutics Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Registrant’s Certifying Accountant, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status8-K - POINT Biopharma Global Inc. (0001811764) (Filer)
- INSIDERSEC Form 4: GOTTLIEB MICHAEL M. was granted 1,156,887 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by HOGUE GERALD L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by JENSEN JESSICA D.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4: MCCANN JOE A. was granted 3,614,153 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4: SILBER ALLAN C was granted 8,864,091 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by DEMERS WILLIAM L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4: FLESHNER NEIL E. was granted 3,820,778 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4 filed by Therapeutics Acquisition Corp.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 4: GOODMAN JONATHAN R. was granted 57,395 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 3 filed by JENSEN JESSICA D.3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 3 filed by Malik Rajesh3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 3 filed by MARGOLIN YAEL3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 3 filed by MCCANN JOE A.3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- INSIDERSEC Form 3 filed by SILBER ALLAN C3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
RACA FAQ
6 questionsWhat is the latest news on RACA?
Quantisnow has not tracked any new filings, ratings or press releases for RACA in the last 30 days. The most recent wire item was published on July 8, 2021.Where does RACA stock trade?
Therapeutics Acquisition Corp. (RACA) is listed on NASDAQ.What sector and industry is RACA in?
Therapeutics Acquisition Corp. operates in the Finance sector, Business Services industry.When did Therapeutics Acquisition Corp. go public?
Therapeutics Acquisition Corp. (RACA) completed its IPO in 2020.What companies are similar to RACA?
Notable peers in the same industry include UBER (Uber Technologies Inc.), BABA (Alibaba Group Holding Limited), MA (Mastercard Incorporated), PDD (PDD Holdings Inc.), V (Visa Inc.). Compare RACA side-by-side with any of them on Quantisnow.How can I track RACA on Quantisnow?
Quantisnow aggregates Therapeutics Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RACA to receive live email and push alerts on every new disclosure.